John Pappajohn - Net Worth and Insider Trading
John Pappajohn Net Worth
The estimated net worth of John Pappajohn is at least $746,239 dollars as of 2024-11-29. John Pappajohn is the Director of Cancer Genetics Inc and owns about 159,372 shares of Cancer Genetics Inc (CGIX) stock worth over $734,705. John Pappajohn is the 10% Owner of Hooper Holmes Inc and owns about 3,443,351 shares of Hooper Holmes Inc (HPHWQ) stock worth over $5,854. John Pappajohn is also the Director, 10% Owner of Emmaus Life Sciences Inc and owns about 186,321 shares of Emmaus Life Sciences Inc (EMMA) stock worth over $5,049. Besides these, John Pappajohn also holds American Caresource Holdings Inc (GNOW) , The WhiteWave Foods Co (XXXX) . Details can be seen in John Pappajohn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Pappajohn has not made any transactions after 2019-05-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John Pappajohn
John Pappajohn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Pappajohn owns 10 companies in total, including Emmaus Life Sciences Inc (EMMA) , Cancer Genetics Inc (CGIX) , and Hooper Holmes Inc (HPHWQ) among others .
Click here to see the complete history of John Pappajohn’s form 4 insider trades.
Insider Ownership Summary of John Pappajohn
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EMMA | Emmaus Life Sciences Inc | 2019-05-23 | director & 10 percent owner |
| CGIX | Cancer Genetics Inc | 2019-01-31 | director |
| HPHWQ | Hooper Holmes Inc | 2017-04-06 | 10 percent owner |
 | | 2016-06-30 | director & 10 percent owner |
| | 2008-04-01 | director & 10 percent owner & President |
| | 2009-03-09 | director |
| | 2009-09-16 | director |
| | 2008-04-01 | director & 10 percent owner & President |
| | 2014-05-19 | director |
| | 2008-04-01 | director & 10 percent owner & President |
John Pappajohn Latest Holdings Summary
John Pappajohn currently owns a total of 5 stocks. Among these stocks, John Pappajohn owns 159,372 shares of Cancer Genetics Inc (CGIX) as of January 31, 2019, with a value of $734,705 and a weighting of 98.45%. John Pappajohn owns 3,443,351 shares of Hooper Holmes Inc (HPHWQ) as of April 6, 2017, with a value of $5,854 and a weighting of 0.78%. John Pappajohn also owns 186,321 shares of Emmaus Life Sciences Inc (EMMA) as of May 23, 2019, with a value of $5,049 and a weighting of 0.68%. The other 2 stocks American Caresource Holdings Inc (GNOW) , The WhiteWave Foods Co (XXXX) have a combined weighting of 0.08% among all his current holdings.
Latest Holdings of John Pappajohn
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CGIX | Cancer Genetics Inc | 2019-01-31 | 159,372 | 4.61 | 734,705 |
| HPHWQ | Hooper Holmes Inc | 2017-04-06 | 3,443,351 | 0.00 | 5,854 |
| EMMA | Emmaus Life Sciences Inc | 2019-05-23 | 186,321 | 0.03 | 5,049 |
| GNOW | American Caresource Holdings Inc | 2016-06-30 | 6,310,463 | 0.00 | 631 |
| XXXX | The WhiteWave Foods Co | 2005-12-20 | 4,141,229 | 0.00 | 0 |
Holding Weightings of John Pappajohn
John Pappajohn Form 4 Trading Tracker
According to the SEC Form 4 filings, John Pappajohn has made a total of 0 transactions in Cancer Genetics Inc (CGIX) over the past 5 years. The most-recent trade in Cancer Genetics Inc is the acquisition of 33,333 shares on January 31, 2019, which cost John Pappajohn around $230,000.
According to the SEC Form 4 filings, John Pappajohn has made a total of 0 transactions in Hooper Holmes Inc (HPHWQ) over the past 5 years. The most-recent trade in Hooper Holmes Inc is the acquisition of 158,509 shares on April 6, 2017, which cost John Pappajohn around $117,297.
According to the SEC Form 4 filings, John Pappajohn has made a total of 0 transactions in Emmaus Life Sciences Inc (EMMA) over the past 5 years. The most-recent trade in Emmaus Life Sciences Inc is the acquisition of 33,333 shares on May 23, 2019, which cost John Pappajohn around $250,000.
More details on John Pappajohn's insider transactions can be found in the Insider Trading History of John Pappajohn table.Insider Trading History of John Pappajohn
- 1
John Pappajohn Trading Performance
GuruFocus tracks the stock performance after each of John Pappajohn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Pappajohn is -24.45%. GuruFocus also compares John Pappajohn's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Pappajohn within 3 months outperforms 6 times out of 43 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John Pappajohn's insider trading performs compared to the benchmark.
Performance of John Pappajohn
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.89 | | | | | |
| Relative Return to S&P 500(%) | -3.29 | | | | | |
John Pappajohn Ownership Network
John Pappajohn Owned Company Details
What does Emmaus Life Sciences Inc do?
Who are the key executives at Emmaus Life Sciences Inc?
John Pappajohn is the director & 10 percent owner of Emmaus Life Sciences Inc. Other key executives at Emmaus Life Sciences Inc include director & Vice Chairman & COO Willis C Lee , director & 10 percent owner & Chairman and CEO Yutaka Niihara , and CIO & SVP George Sekulich .
Emmaus Life Sciences Inc (EMMA) Insider Trades Summary
Over the past 18 months, John Pappajohn made no insider transaction in Emmaus Life Sciences Inc (EMMA). Other recent insider transactions involving Emmaus Life Sciences Inc (EMMA) include a net purchase of 120,700 shares made by Seah H. Lim , and a net purchase of 251,809 shares made by Willis C Lee .
In summary, during the past 3 months, insiders sold 0 shares of Emmaus Life Sciences Inc (EMMA) in total and bought 20,000 shares, with a net purchase of 20,000 shares. During the past 18 months, 38,500 shares of Emmaus Life Sciences Inc (EMMA) were sold and 411,009 shares were bought by its insiders, resulting in a net purchase of 372,509 shares.
Emmaus Life Sciences Inc (EMMA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Emmaus Life Sciences Inc Insider Transactions
John Pappajohn Mailing Address
Above is the net worth, insider trading, and ownership report for John Pappajohn. You might contact John Pappajohn via mailing address: 1660 Walt Whitman Road, Suite 105, Melville Ny 11747.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
